LSTM and partners develop molecule that may lead to first synthetic one-dose antimalarial

(Liverpool School of Tropical Medicine) Researchers at LSTM, working in partnership with the University of Liverpool and other colleagues, have developed a molecule which has the potential to become the first fully synthetic, one-dose treatment for malaria.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news